Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 3Warts 1Uterine Cervical Dysplasia 1Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myeloid, Acute 1Human Papillomavirus-Related Carcinoma 1Acquired Immunodeficiency Syndrome 1

Interventions

Solutions 2Saline Solution 2Hydrogen Peroxide 2plerixafor 1human papillomavirus vaccine, L1 type 16, 18 1Vaccination 1VP-102 1Sodium Chloride 1Human Papillomavirus Recombinant Vaccine nonavalent 1Cantharidin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Warts × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all
NCT05625633 2024-04-05

Human Papillomavirus (HPV) Vaccination vs. Placebo for the Treatment of Refractory Cutaneous Warts

Western Institute for Veterans Research

Phase 2/3 Recruiting
120 enrolled

Warts, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡